Quantitative Assessment of the Quality of External Radiotherapy Planning for Patients with Prostate Cancer-Reference-Cited by-同舟云学术

Quantitative Assessment of the Quality of External Radiotherapy Planning for Patients with Prostate Cancer

Published:2022-07-12 Issue:2 Volume:94 Page:12-19
ISSN:1810-200X
Container-title:Meditsinskaya Fizika
language:
Short-container-title:Med. fiz.

Author:

Lazareva Yu. A.¹,Lebedenko I. M.²

Affiliation:

1. Lipetsk Regional Oncological Dispensary

2. N.N. Blokhin National Medical Research Center of Oncology

Abstract

Purpose. To quantify the quality of treatment planning for patients with prostate cancer for three different radiotherapy technologies. Materials and methods. The quality of irradiation planning was assessed using the index of homogeneity, conformality and comparison of critical organs doses for 40 patients with prostate cancer using various irradiation technologies: 3D conformal radiation therapy 3DCRT, radiation therapy with intensity modulation IMRT, radiation therapy with intensity modulation in rotation mode RapidArc. The technologies are implemented on conventional electron accelerators of the Clinac iX (Varian, USA), Clinac 2300 CD (Varian, USA) and UniquePower (Varian, USA) models with a nominal photon radiation energy 6 and 18 MeV. Results. The dependences of the homogeneity indices HI, conformality CI within the target, and critical organs doses on the irradiation technology for patients with prostate cancer were obtained. Taking into account the predictive capabilities of the HI index for relapse-free survival, the optimal technology for irradiating patients was chosen. It has been shown that Rapid Arc technology dominates for prostate cancer.

Publisher

Association of Medical Physicists in Russia

Reference13 articles.

1. Ferlay J et.al. Cancer Incidence and Mortality Worldwide. IARC Cancer Base. 2012;11. DOI: 10.1002/ijc.29210. Epub 2014 Oct 9.

2. Беликова АА, Герасимов ВА, Иванов СА и др. Факторы риска локального и дистантного прогрессирования у больных немелкоклеточным раком легкого и молочной железы после облучения всего объема головного мозга. Медицинская физика. 2021; (2 (90)): 29-38. [Belikova AA, Gerasimov VA, Ivanov SA et al. Risk factors for local and distant progression in patients with non-small cell lung and breast cancer after whole brain irradiation. Medical physics. 2021; (2 (90)): 29-38 (In Russian)].

3. Лебеденко ИМ, Быкова ЮБ, Болдырева ВА и др. Оценка распределения дозы в планируемом объеме мишени с применением индекса гомогенности. Медицинская физика. 2017; (1 (73)): 34-8 [Lebedenko IM, Bykova YuB, Boldyreva VA et al. Estimation of dose distribution in the planned target volume using the homogeneity index. Medical physics. 2017; (1 (73)): 34-8 (In Russian)].

4. Лебеденко ИМ, Кравец ОА, Быкова ЮБ и др. Количественная оценка качества планирования дистанционной составляющей лучевой терапии больных раком шейки матки. Вопросы онкологии. 2016; 6: 827-30 [Lebedenko IM, Kravets OA, Bykova YuB et al. Quantitative assessment of the quality of planning the remote radiоtherapy in cervical cancer patients. Problems in Oncology. 2016; 6: 827-30 (In Russian)].

5. Lebedenko IM, Romanova EA, Belova AA et al. Quantitative assessment of the quality of treatment planning for patients with advanced cervical cancer. Biomedical Engineering. 2018; 52 (4): 263-6.